IMS Health expands with SDI Health acquisition

NEW YORK — Healthcare market research firm IMS Health will buy privately held market research firm SDI Health, IMS said.

Terms of the transaction were not disclosed, but the deal would bring together two of the leading healthcare analytics companies. In terms of drug industry analytics, IMS focuses on drug sales and dispensed prescriptions, while SDI provides data on prescriptions written by physicians and other prescribers.

IMS, which has existed for more than 55 years and operates in more than 100 countries, said the acquisition would enable more robust patient and specialty analytics while allowing it to reach out to a broader set of stakeholders.